Financial Ratios Bayer AG

Stocks

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate Other stock markets 16:14:00 20/07/2026 +03			5-day change	1st Jan Change
47.62 ^EUR	-1.74%		-4.41%	+28.94%

07-17	Bayer Ag and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials	CI
07-17	BAYER AG : JP Morgan keeps its Buy rating	ZD

f5386ce2c6.yc3msLpn-7km0_0tNPujECLZFfckwcI1uHJ9IUX2Tos.vbuz4ewhqIpkpKJ_c5PRam6zWoJU8e9B0DUFaXLDNO6r4Nfiwj28zEWWjg

Published financial data: BAYER AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	44.08B	50.74B	47.64B	46.61B	45.58B
Total Revenues	44.08B	50.74B	47.64B	46.61B	45.58B
Cost of Goods Sold, Total	17.04B	18.89B	19.75B	20.83B	18.53B
Gross Profit	27.04B	31.85B	27.89B	25.78B	27.05B
Selling General & Admin Expenses, Total	14.61B	16.04B	14.71B	16.76B	16.02B
R&D Expenses	5.33B	6.17B	5.84B	5.97B	5.65B
Other Operating Expenses	27M	528M	-457M	-78M	262M
Other Operating Expenses, Total	19.96B	22.73B	20.09B	22.66B	21.94B
Operating Income	7.07B	9.12B	7.8B	3.12B	5.11B
Interest Expense, Total	-1.29B	-1.06B	-1.13B	-1.95B	-1.93B
Interest And Investment Income	346M	379M	484M	521M	471M
Net Interest Expenses	-940M	-679M	-650M	-1.42B	-1.46B
Income (Loss) On Equity Invest.	49M	-450M	-335M	-295M	-70M
Currency Exchange Gains (Loss)	-385M	-219M	-449M	-203M	-169M
Other Non Operating Income (Expenses)	23M	-844M	-788M	1.46B	1.46B
EBT, Excl. Unusual Items	5.82B	6.93B	5.58B	2.66B	4.87B
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-734M	-6.69B	-3.26B	-
Gain (Loss) On Sale Of Investments	-39M	-150M	-11M	-3M	-20M
Gain (Loss) On Sale Of Assets	86M	-	-	-	-
Asset Writedown	132M	1.69B	152M	207M	469M
Insurance Settlements	-	-	-	-	-
Legal Settlements	-3.69B	-791M	-889M	-548M	-7.85B
Other Unusual Items	-262M	-2.28B	240M	-1.38B	-600M
EBT, Incl. Unusual Items	2.05B	4.67B	-1.62B	-2.33B	-3.13B
Income Tax Expense	1.02B	504M	1.32B	212M	466M
Earnings From Continuing Operations	1.02B	4.17B	-2.94B	-2.55B	-3.6B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	1.02B	4.17B	-2.94B	-2.55B	-3.6B
Minority Interest	-22M	-16M	1M	-6M	-25M
Net Income - (IS)	1B	4.15B	-2.94B	-2.55B	-3.62B
Net Income to Common Incl Extra Items	1B	4.15B	-2.94B	-2.55B	-3.62B
Net Income to Common Excl. Extra Items	1B	4.15B	-2.94B	-2.55B	-3.62B
Per Share Items
Net EPS - Basic	1.02	4.22	-2.99	-2.6	-3.68
Basic EPS - Continuing Operations	1.02	4.22	-2.99	-2.6	-3.68
Basic Weighted Average Shares Outstanding	982M	982M	982M	982M	982M
Net EPS - Diluted	1.02	4.22	-2.99	-2.6	-3.68
Diluted EPS - Continuing Operations	1.02	4.22	-2.99	-2.6	-3.68
Diluted Weighted Average Shares Outstanding	982M	982M	982M	982M	982M
Normalized Basic EPS	3.68	4.39	3.55	1.68	3.07
Normalized Diluted EPS	3.68	4.39	3.55	1.68	3.07
Dividend Per Share	2	2.4	0.11	0.11	0.11
Payout Ratio	199.3	47.83	-80.89	-4.23	-2.98
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	8.34B	12.7B	11.33B	6.81B	8.87B
EBITA	7.19B	11.52B	10.12B	5.57B	7.57B
EBIT	7.07B	9.12B	7.8B	3.12B	5.11B
EBITDAR	8.63B	13.15B	11.79B	7.27B	9.18B
Effective Tax Rate - (Ratio)	50.05	10.79	-81.49	-9.08	-14.89
Current Domestic Taxes	604M	912M	359M	58M	-53M
Current Foreign Taxes	1.02B	1.66B	884M	887M	1.05B
Total Current Taxes	1.63B	2.57B	1.24B	945M	995M
Total Deferred Taxes	-602M	-2.07B	78M	-733M	-529M
Normalized Net Income	3.61B	4.31B	3.49B	1.65B	3.02B
Interest Capitalized	30M	38M	53M	61M	56M
Interest on Long-Term Debt	-	-	72M	77M	77M
Non-Cash Pension Expense	62M	78M	125M	87M	49M
Supplemental Operating Expense Items
Selling and Marketing Expenses	12.27B	13.55B	12.57B	13.09B	12.4B
General and Administrative Expenses	2.26B	2.49B	2.14B	2.18B	2.11B
Research And Development Expense From Footnotes	5.72B	7.4B	5.63B	6.39B	5.98B
Net Rental Expense, Total	286M	447M	461M	468M	306M
Imputed Operating Lease Interest Expense	72.87M	94.98M	101M	175M	124M
Imputed Operating Lease Depreciation	213M	352M	360M	293M	182M
Stock-Based Comp., Other (Total)	238M	365M	153M	58M	440M
Total Stock-Based Compensation	238M	365M	153M	58M	440M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.56B	5.17B	5.91B	6.19B	6.67B
Short Term Investments	669M	32M	755M	75M	36M
Trading Asset Securities, Total	2.51B	4.95B	3.92B	1.82B	1.15B
Total Cash And Short Term Investments	7.74B	10.15B	10.59B	8.09B	7.86B
Accounts Receivable, Total	10.05B	10.32B	9.35B	8.97B	9.08B
Other Receivables	2.93B	3.13B	3.17B	3.22B	3.09B
Notes Receivable	-	-	-	-	-
Total Receivables	12.98B	13.45B	12.52B	12.19B	12.17B
Inventory	11.31B	13.64B	13.95B	13.47B	12.38B
Other Current Assets, Total	545M	521M	500M	702M	507M
Total Current Assets	32.58B	37.76B	37.56B	34.44B	32.91B
Gross Property Plant And Equipment	26.19B	28.34B	29.26B	31.22B	29.81B
Accumulated Depreciation	-13.5B	-14.66B	-15.94B	-17.77B	-17.16B
Net Property Plant And Equipment	12.69B	13.67B	13.32B	13.46B	12.65B
Long-term Investments	2.61B	2.9B	3.06B	3.02B	2.67B
Goodwill	40.11B	39.65B	32.3B	30.02B	28.06B
Other Intangibles, Total	21.96B	20.42B	19.82B	18.43B	20.62B
Accounts Receivable Long-Term	24M	24M	23M	20M	34M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	4.58B	5.6B	5.47B	6.16B	5.74B
Deferred Charges Long-Term	4.31B	3.8B	3.56B	3.72B	39M
Other Long-Term Assets, Total	1.38B	1.06B	1.15B	1.58B	1.81B
Total Assets	120B	125B	116B	111B	105B
Liabilities
Accounts Payable, Total	6.79B	7.54B	7.46B	7.52B	7.08B
Accrued Expenses, Total	3.5B	3.57B	2.5B	3.49B	3.75B
Current Portion of Long-Term Debt	4.16B	7.58B	6.54B	5B	5.49B
Current Portion of Leases	236M	282M	294M	309M	259M
Current Income Taxes Payable	686M	1.06B	619M	547M	678M
Unearned Revenue Current, Total	4.09B	4.2B	3.91B	3.68B	3.76B
Other Current Liabilities	9.94B	10.85B	8.15B	8.4B	11.56B
Total Current Liabilities	29.4B	35.08B	29.46B	28.95B	32.58B
Long-Term Debt	35.55B	32.84B	37.23B	34.56B	30.81B
Long-Term Leases	929M	952M	944M	939M	1.03B
Unearned Revenue Non Current	810M	602M	467M	343M	209M
Pension & Other Post Retirement Benefits	7.18B	4.39B	4.01B	3.31B	2.09B
Deferred Tax Liability Non Current	931M	727M	790M	865M	769M
Other Non Current Liabilities	12.27B	11.36B	10.28B	9.84B	10.99B
Total Liabilities	87.07B	85.95B	83.18B	78.8B	78.48B
Common Stock, Total	2.52B	2.52B	2.52B	2.52B	2.52B
Retained Earnings	13.34B	17.23B	12.18B	9.87B	6.73B
Comprehensive Income and Other	17.16B	19.02B	18.24B	19.53B	16.71B
Total Common Equity	33.02B	38.77B	32.93B	31.91B	25.95B
Minority Interest	148M	153M	151M	137M	116M
Total Equity	33.17B	38.93B	33.08B	32.04B	26.06B
Total Liabilities And Equity	120B	125B	116B	111B	105B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	982M	982M	982M	982M	982M
ECS Total Common Shares Outstanding	982M	982M	982M	982M	982M
Book Value / Share	33.61	39.47	33.52	32.48	26.41
Tangible Book Value	-29.04B	-21.29B	-19.19B	-16.54B	-22.74B
Tangible Book Value Per Share	-29.56	-21.67	-19.54	-16.83	-23.14
Total Debt	40.87B	41.65B	45.01B	40.81B	37.58B
Net Debt	33.13B	31.5B	34.42B	32.72B	29.72B
Debt Equivalent of Unfunded Proj. Benefit Obligation	6.26B	3.58B	3.06B	1.91B	691M
Debt Equivalent Oper. Leases	2.29B	3.58B	3.69B	3.74B	2.45B
Minority Interest, Total (Incl. Fin. Div)	148M	153M	151M	137M	116M
Equity Method Investments, Total	629M	893M	850M	820M	546M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	2.01B	2.7B	2.52B	2.08B	2.07B
Inventories - Work In Process, Total	9.16B	10.72B	11.29B	11.23B	10.18B
Inventories - Others	139M	221M	140M	152M	128M
Land - (BS)	9.83B	10.48B	10.74B	11.57B	11.22B
Machinery, Total	13.24B	14.58B	15.35B	16.64B	16.06B
Full Time Employees	95.95K	97.92K	96.93K	91.86K	87.28K
Accumulated Allowance for Doubtful Accounts (Supple)	654M	700M	642M	576M	617M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1B	4.15B	-2.94B	-2.55B	-3.62B
Depreciation & Amortization - CF	1.49B	1.54B	1.59B	1.6B	1.63B
Amortization of Goodwill and Intangible Assets - (CF)	117M	2.4B	2.32B	2.45B	2.46B
Depreciation & Amortization, Total	1.61B	3.95B	3.91B	4.05B	4.09B
(Gain) Loss From Sale Of Asset	-217M	-1.69B	-152M	-207M	-469M
Asset Writedown & Restructuring Costs	1.45B	2.55B	6.11B	4.73B	-1.3B
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	194M	828M	2.26B	1.26B	1.3B
Change In Accounts Receivable	-61M	269M	689M	197M	-852M
Change In Inventories	-173M	-2.17B	-430M	521M	475M
Change In Accounts Payable	854M	612M	82M	-120M	-176M
Change in Other Net Operating Assets	436M	-1.41B	-4.41B	-513M	6.49B
Cash from Operations	5.09B	7.09B	5.12B	7.37B	5.93B
Capital Expenditure	-2.61B	-2.95B	-2.75B	-2.78B	-2.49B
Sale of Property, Plant, and Equipment	373M	1.13B	215M	295M	415M
Cash Acquisitions	-1.34B	-89M	-662M	-184M	-196M
Divestitures	-6M	2.29B	8M	17M	-2M
Investment in Marketable and Equity Securities, Total	4.3B	-2.98B	-306M	2.32B	661M
Other Investing Activities, Total	137M	218M	-21M	489M	339M
Cash from Investing	855M	-2.38B	-3.52B	164M	-1.27B
Long-Term Debt Issued, Total	6.59B	6.63B	16.28B	5.82B	6.28B
Total Debt Issued	6.59B	6.63B	16.28B	5.82B	6.28B
Long-Term Debt Repaid, Total	-9.04B	-7.6B	-13.03B	-10.83B	-8.33B
Total Debt Repaid	-9.04B	-7.6B	-13.03B	-10.83B	-8.33B
Issuance of Common Stock	-	-	23M	-	-
Repurchase of Common Stock	-	-10M	-24M	-16M	-14M
Common Dividends Paid	-1.99B	-1.98B	-2.38B	-108M	-108M
Common & Preferred Stock Dividends Paid	-1.99B	-1.98B	-2.38B	-108M	-108M
Other Financing Activities, Total	-1.2B	-1.25B	-1.55B	-2.04B	-1.72B
Cash from Financing	-5.64B	-4.22B	-679M	-7.18B	-3.88B
Foreign Exchange Rate Adjustments	35M	112M	-185M	-68M	-291M
Miscellaneous Cash Flow Adjustments	39M	3M	-	-2M	-5M
Net Change in Cash	373M	607M	736M	284M	480M
Supplemental Items
Cash Interest Paid	1.23B	1.3B	1.54B	1.98B	1.7B
Cash Income Tax Paid (Refund)	2.16B	2.03B	1.77B	1.22B	1.24B
Levered Free Cash Flow	-1.38B	5.85B	1.52B	3.68B	8.53B
Unlevered Free Cash Flow	-579M	6.51B	2.23B	4.9B	9.74B
Change In Net Working Capital	4.23B	557M	3.96B	-1.62B	-4.5B
Net Debt Issued / Repaid	-2.45B	-974M	3.25B	-5.02B	-2.04B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.73	4.65	4.04	1.71	2.97
Return on Total Capital	6.03	7.37	6.14	2.58	4.68
Return On Equity %	3.2	11.56	-8.17	-7.82	-12.37
Return on Common Equity	3.15	11.56	-8.2	-7.87	-12.51
Margin Analysis
Gross Profit Margin %	61.33	62.78	58.55	55.3	59.35
SG&A Margin	33.15	31.6	30.89	35.97	35.16
EBITDA Margin %	18.92	25.04	23.79	14.6	19.46
EBITA Margin %	16.31	22.71	21.23	11.95	16.61
EBIT Margin %	16.04	17.98	16.37	6.68	11.22
Income From Continuing Operations Margin %	2.32	8.21	-6.18	-5.46	-7.89
Net Income Margin %	2.27	8.18	-6.17	-5.48	-7.94
Net Avail. For Common Margin %	2.27	8.18	-6.17	-5.48	-7.94
Normalized Net Income Margin	8.2	8.5	7.32	3.55	6.63
Levered Free Cash Flow Margin	-3.14	11.52	3.19	7.9	18.72
Unlevered Free Cash Flow Margin	-1.31	12.83	4.68	10.51	21.37
Asset Turnover
Asset Turnover	0.37	0.41	0.4	0.41	0.42
Fixed Assets Turnover	3.61	3.85	3.53	3.48	3.49
Receivables Turnover (Average Receivables)	4.5	4.98	4.84	5.09	5.05
Inventory Turnover (Average Inventory)	1.53	1.51	1.43	1.52	1.43
Short Term Liquidity
Current Ratio	1.11	1.08	1.27	1.19	1.01
Quick Ratio	0.7	0.67	0.78	0.7	0.61
Operating Cash Flow to Current Liabilities	0.17	0.2	0.17	0.25	0.18
Days Sales Outstanding (Average Receivables)	81.17	73.26	75.34	71.94	72.3
Days Outstanding Inventory (Average Inventory)	238.5	241.1	254.93	240.83	254.59
Average Days Payable Outstanding	130.81	123.37	136.5	134.65	152.79
Cash Conversion Cycle (Average Days)	188.86	190.99	193.77	178.12	174.1
Long Term Solvency
Total Debt/Equity	123.23	107	136.06	127.36	144.19
Total Debt / Total Capital	55.2	51.69	57.64	56.02	59.05
LT Debt/Equity	109.99	86.81	115.41	110.78	122.14
Long-Term Debt / Total Capital	49.27	41.94	48.89	48.72	50.02
Total Liabilities / Total Assets	72.42	68.83	71.55	71.09	75.07
EBIT / Interest Expense	5.5	8.62	6.88	1.6	2.65
EBITDA / Interest Expense	6.75	12.35	10.32	3.68	4.77
(EBITDA - Capex) / Interest Expense	4.72	9.57	7.9	2.25	3.48
Total Debt / EBITDA	4.71	3.19	3.84	5.7	4.08
Net Debt / EBITDA	3.82	2.41	2.94	4.57	3.23
Total Debt / (EBITDA - Capex)	6.73	4.12	5.02	9.3	5.6
Net Debt / (EBITDA - Capex)	5.46	3.11	3.84	7.46	4.43
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6.48	15.1	-6.11	-2.16	-2.21
Gross Profit, 1 Yr. Growth %	5.31	17.82	-12.44	-7.78	4.94
EBITDA, 1 Yr. Growth %	-16.83	16.81	-10.81	-35.59	30.31
EBITA, 1 Yr. Growth %	-18.25	19.33	-12.23	-40.44	35.9
EBIT, 1 Yr. Growth %	1.42	22.02	-14.49	-55.72	64.14
Earnings From Cont. Operations, 1 Yr. Growth %	-106.57	307.63	-170.62	-13.46	41.2
Net Income, 1 Yr. Growth %	-109.53	315	-170.87	-13.23	41.85
Normalized Net Income, 1 Yr. Growth %	6.08	12.09	-19.19	-60.04	82.66
Diluted EPS Before Extra, 1 Yr. Growth %	-106.42	314.58	-170.94	-13.15	41.72
Accounts Receivable, 1 Yr. Growth %	5.22	2.64	-9.39	-4.01	1.21
Inventory, 1 Yr. Growth %	3.22	20.52	2.28	-3.44	-8.09
Net Property, Plant and Equip., 1 Yr. Growth %	8.23	7.77	-2.58	1.01	-6
Total Assets, 1 Yr. Growth %	2.94	3.86	-6.9	-4.65	-5.69
Tangible Book Value, 1 Yr. Growth %	7.71	-26.68	-9.86	-13.84	12.44
Common Equity, 1 Yr. Growth %	8.18	17.42	-15.08	-3.09	-18.68
Cash From Operations, 1 Yr. Growth %	3.79	39.38	-27.86	43.99	-19.52
Capital Expenditures, 1 Yr. Growth %	7.98	12.95	-6.71	0.98	-10.48
Levered Free Cash Flow, 1 Yr. Growth %	-109.27	377.87	-74.03	398.71	131.65
Unlevered Free Cash Flow, 1 Yr. Growth %	-103.65	260.61	-65.78	180.01	98.75
Dividend Per Share, 1 Yr. Growth %	0	20	-95.42	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.61	10.71	3.96	-4.16	-2.19
Gross Profit, 2 Yr. CAGR %	-0.16	11.39	1.57	-10.05	-1.63
EBITDA, 2 Yr. CAGR %	-12.15	12.55	2.07	-26.81	-8.39
EBITA, 2 Yr. CAGR %	-12.24	14.49	2.34	-30.49	-10.04
EBIT, 2 Yr. CAGR %	0.65	14.38	2.14	-41.56	-14.75
Earnings From Cont. Operations, 2 Yr. CAGR %	-34.88	-48.26	69.67	-21.82	10.54
Net Income, 2 Yr. CAGR %	-50.56	-37.12	71.49	-21.58	10.94
Normalized Net Income, 2 Yr. CAGR %	0.11	12.53	-4.83	-38.1	-14.56
Diluted EPS Before Extra, 2 Yr. CAGR %	-35.35	-48.4	71.49	-21.51	10.94
Accounts Receivable, 2 Yr. CAGR %	-7.22	3.92	-3.57	-6.74	-1.43
Inventory, 2 Yr. CAGR %	3.07	11.54	11.03	-0.62	-5.79
Net Property, Plant and Equip., 2 Yr. CAGR %	0.83	8	2.46	-0.8	-2.56
Total Assets, 2 Yr. CAGR %	-2.38	3.4	-1.67	-5.78	-5.17
Tangible Book Value, 2 Yr. CAGR %	16.84	-11.14	-18.71	-11.87	8.84
Common Equity, 2 Yr. CAGR %	-16.41	12.71	-0.14	-9.28	-11.23
Cash From Operations, 2 Yr. CAGR %	-21.25	20.28	0.27	1.92	7.65
Capital Expenditures, 2 Yr. CAGR %	-0.74	10.44	2.65	-2.94	-4.92
Levered Free Cash Flow, 2 Yr. CAGR %	-51.15	-37.39	11.4	-20.63	239.89
Unlevered Free Cash Flow, 2 Yr. CAGR %	-70.93	-35.93	11.09	-13.23	135.91
Dividend Per Share, 2 Yr. CAGR %	-15.48	9.54	-76.55	-78.59	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.26	5.23	4.79	1.87	-3.51
Gross Profit, 3 Yr. CAGR %	4.53	5.51	2.8	-1.58	-5.3
EBITDA, 3 Yr. CAGR %	5.3	5.53	4.15	-14.47	-11.29
EBITA, 3 Yr. CAGR %	7.14	7.29	4.78	-16.77	-13.08
EBIT, 3 Yr. CAGR %	18.43	9.33	3.81	-25.31	-17.55
Earnings From Cont. Operations, 3 Yr. CAGR %	-9.74	20.01	-42.61	35.56	-4.8
Net Income, 3 Yr. CAGR %	-16.13	0.48	-34.56	36.66	-4.45
Normalized Net Income, 3 Yr. CAGR %	21.38	6.16	0.77	-24.55	-11.21
Diluted EPS Before Extra, 3 Yr. CAGR %	-11.33	20.11	-42.62	36.7	-4.42
Accounts Receivable, 3 Yr. CAGR %	-4.97	-4.05	-0.72	-3.71	-4.16
Inventory, 3 Yr. CAGR %	0.54	8.59	8.36	5.98	-3.17
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.66	3.1	4.35	1.98	-2.56
Total Assets, 3 Yr. CAGR %	-1.74	-0.34	-0.16	-2.67	-5.75
Tangible Book Value, 3 Yr. CAGR %	6.63	0.03	-10.71	-17.12	2.21
Common Equity, 3 Yr. CAGR %	-10.45	-6.38	2.56	-1.14	-12.53
Cash From Operations, 3 Yr. CAGR %	-13.7	-4.75	1.43	13.13	-5.79
Capital Expenditures, 3 Yr. CAGR %	0.23	3.63	4.39	2.09	-5.52
Levered Free Cash Flow, 3 Yr. CAGR %	-33.95	0.32	-53.31	44.39	13.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	-53.28	-1.68	-48.02	39.5	14.38
Dividend Per Share, 3 Yr. CAGR %	-10.61	-5.01	-61.97	-61.97	-64.21
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.76	7.7	5.33	1.37	1.94
Gross Profit, 5 Yr. CAGR %	2.76	6.01	3.33	-1.01	1.05
EBITDA, 5 Yr. CAGR %	-1.32	7.15	9.66	-8.84	-2.43
EBITA, 5 Yr. CAGR %	-2.3	7.31	11.6	-9.81	-2.96
EBIT, 5 Yr. CAGR %	1.52	5.82	12.87	-14.9	-6.01
Earnings From Cont. Operations, 5 Yr. CAGR %	-22.92	5.1	16.18	1.1	-25.4
Net Income, 5 Yr. CAGR %	-26.08	-10.77	11.65	-9.01	-19.18
Normalized Net Income, 5 Yr. CAGR %	-0.07	3.05	11.53	-14.44	-2.38
Diluted EPS Before Extra, 5 Yr. CAGR %	-25.7	2.52	15.44	1.32	-25.31
Accounts Receivable, 5 Yr. CAGR %	-1.73	3.75	-4.41	-5.13	-1.01
Inventory, 5 Yr. CAGR %	6.12	15.79	4.61	4.81	2.46
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.66	12.37	0.58	1.52	1.53
Total Assets, 5 Yr. CAGR %	7.89	10.71	-1.71	-2.56	-2.19
Tangible Book Value, 5 Yr. CAGR %	92.25	13.5	-4.33	-4.92	-3.35
Common Equity, 5 Yr. CAGR %	1.71	1.05	-6.46	-7.55	-3.2
Cash From Operations, 5 Yr. CAGR %	-10.95	-2.7	-8.36	-2.13	3.88
Capital Expenditures, 5 Yr. CAGR %	0.25	4.5	1.19	0.95	0.56
Levered Free Cash Flow, 5 Yr. CAGR %	-5.13	5.92	-20.55	-8.65	-10.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	-23.5	6.21	-17.06	-6.47	-9.29
Dividend Per Share, 5 Yr. CAGR %	-5.83	-3.04	-47.66	-47.66	-44.01